| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:1184.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Istituto Nazionale Neurologico "C. Besta" (G.S., P.S., G.R., F.G.), Milano, Italy; the Institute of Biomedical Technologies (M.M.), National Research Council, Segrate (Milano), Italy; and the Niguarda CaGranda Hospital (I.P.), Milano, Italy.
Address reprint requests to Floriano Girotti, MD, PhD, Istituto Nazionale Neurologico "C. Besta," Via Celoria 11, 20131 Milano, Italy.
Background and Purpose Sympathetic hyperactivity is a contributing cause of vascular disorders because it increases blood pressure, blood sugar, and blood lipids. Pervasive compromise of the central and peripheral autonomic nervous systems is common in idiopathic Parkinson disease (IPD) resulting in reduced sympathetic and parasympathetic function. We hypothesized that IPD was associated with reduced prevalence of cardiovascular disease risk factors as a result of reduced sympathetic activity.
Methods We performed a retrospective case-control study on 178 newly diagnosed consecutive IPD patients, and 533 age- (±3 years) and sex-matched controls with other neurological diseases seen over the same period at the same hospital. For each case and control the following were noted on admission: smoking, diabetes, hypertension, body mass index, serum glucose, plasma cholesterol, triglycerides and total lipid levels, and blood pressure.
Results Diabetes, history of smoking, high blood pressure, high blood glucose, high blood cholesterol, and triglycerides were significantly less frequent in IPD than controls.
Conclusions IDP is a natural model of impaired hypothalamic-pituitary-adrenal axis activity and generalized sympathetic denervation. We interpret the association of untreated IPD with reduced vascular diseases risk factors as attributable to reduced autonomic activity, suggesting that autonomic hyperactivity may be involved in the pathogenesis of vascular disorders.
Key Words: cardiovascular disease cerebrovascular disease Parkinson disease risk factors
This article has been cited by other articles:
![]() |
J. A. Driver, A. Smith, J. E. Buring, J. M. Gaziano, T. Kurth, and G. Logroscino Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease Diabetes Care, October 1, 2008; 31(10): 2003 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Becker, G. P. Brobert, S. Johansson, S. S. Jick, and C. R. Meier Diabetes in Patients With Idiopathic Parkinson's Disease Diabetes Care, September 1, 2008; 31(9): 1808 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto Total cholesterol and the risk of Parkinson disease Neurology, May 20, 2008; 70(21): 1972 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Driver, T. Kurth, J. E. Buring, J. M. Gaziano, and G. Logroscino Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study Neurology, April 15, 2008; 70(16_Part_2): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikeda, H. Kashihara, M. Tamura, O. Kano, K. Iwamoto, Y. Iwasaki, G. Hu, P. Jousilahti, and J. Tuomilehto BODY MASS INDEX AND THE RISK OF PARKINSON DISEASE Neurology, June 12, 2007; 68(24): 2156 - 2157. [Full Text] [PDF] |
||||
![]() |
G. Hu, P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto Type 2 Diabetes and the Risk of Parkinson's Disease Diabetes Care, April 1, 2007; 30(4): 842 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Friedman Reduced Autonomic Activity in Parkinson Disease Patients Stroke, September 1, 2006; 37(9): 2217 - 2217. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |